NLS Pharmaceutics News and Activities

Acquisition, funding and merger involving NLS Pharmaceutics.

• NLS Pharmaceutics and Kadimastem have announced they will merge  (posted on August 5 2024)..

View the org chart displaying its 7 main executives

Most searched biographies at NLS Pharmaceutics

• Alexander Zwyer, Chief Executive Officer
• Ronald Hafner, Chairman of the Board
• Gian-Marco Rinaldi, Director

Create your alert
to follow the executive moves at NLS Pharmaceutics.

NLS Pharmaceutics has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by NLS Pharmaceutics

• Press Releases | NLS Pharmaceutics
• News | NLS Pharmaceutics

Social media about NLS Pharmaceutics

• NLS Pharmaceutics on Wikipedia, Google News & Yahoo Finance
• NLS Pharmaceutics on LinkedIn, X (Twitter) & YouTube